Editor's Note: The emergence of targeted therapy has ushered in an era of precision medicine for non-small cell lung cancer (NSCLC), leveraging specific targets on tumor cells to block growth…

Editor’s Note: At the 2024 European Society for Medical Oncology (ESMO) Asia Annual Meeting, nine TiP abstracts focused on colorectal cancer from China were presented. Previously, we summarized four of…

Editor’s Note: The European Society for Medical Oncology (ESMO) Asia Annual Meeting was held in Singapore, focusing on the latest oncology advancements in Asia. This conference provided a platform for…

Editor’s Note: In recent years, breakthroughs in new drugs and therapeutic targets for gastrointestinal tumors have brought renewed hope for patients. At the 2024 European Society for Medical Oncology Asia…

Editor's Note: In recent years, advancements in immunotherapy and targeted therapy have significantly contributed to a more personalized and precise approach to the treatment of advanced gastric cancer. As the…

Editor's Note: According to the latest data released by the National Cancer Center, over 350,000 new cases of gastric cancer are diagnosed annually in China, making it the fifth most…

Editor’s Note: Recent years have witnessed significant breakthroughs in perioperative therapy for gastric cancer. Clinical studies, such as the RESOLVE trial, have demonstrated the efficacy and safety of neoadjuvant therapy…

Editor’s Note: Prostate cancer is one of the most prevalent malignant tumors in men worldwide. For localized cases, radical prostatectomy or radiotherapy can achieve a cure, but some patients experience…

Gastric cancer remains a significant threat to human health. While breakthroughs in chemotherapy, targeted therapy, and immunotherapy have brought hope to patients, radical surgery remains the cornerstone of gastric cancer management. Recent years have seen substantial advancements in surgical treatment, including the refinement of standard radical gastrectomy, the development of minimally invasive techniques such as laparoscopic surgery, the establishment of perioperative multimodal treatment strategies for advanced gastric cancer, and the emergence of precision surgical approaches. At the 2024 CSCO Gastric Cancer Expert Committee Academic Conference, Dr. Jiangpeng Wei from the Department of Gastrointestinal Surgery, The First Affiliated Hospital of Air Force Medical University, provided an overview of key trends in gastric cancer surgery. The key points are summarized below.

At the European Society for Medical Oncology Asia Congress 2024 (ESMO Asia 2024), Dr. Danbo Wang from Liaoning Cancer Hospital presented the latest findings from the DUBHE-C-204 study during the Gynecological Oncology Oral Abstracts session (Abstract No. 373O). Oncology Frontier had the privilege of interviewing Professor Wang on-site to discuss the study's key findings and share highlights from this year’s conference.